OKYO Pharma Corporation Result of General Meeting and Corporate Update (2717H)

TIDMOKYO

RNS Number : 2717H

OKYO Pharma Corporation

09 March 2018

9 March 2018

For immediate release

OKYO Pharma Corporation

Result of General Meeting

Corporate Update

OKYO Pharma Corporation (the "Company") (AIM: OKYO) announces that the resolution put to Shareholders at the General Meeting held earlier today was duly passed. The resolution was proposed as a special resolution of Shareholders to:

   (a)          change the name of the Company to OKYO Pharma Limited with effect from Migration; 

(b) approve the Migration to Guernsey; adopt, with effect from Migration, the Company's new memorandum and articles of incorporation compliant with Guernsey law, in place of the Company's existing memorandum and Articles;

   (c)           disapply the pre-emption rights as set out in the New Articles; and 
   (d)          approve Cancellation of admission of its Ordinary Shares from trading on AIM. 

As previously announced, cancellation of admission of its Ordinary Shares from trading on AIM will take effect at 7.00 a.m. on 23 March 2018.

Broker

As announced on 2 March 2018, the Company is seeking to appoint a new broker as soon as possible and a further announcement will be made when this appointment is made.

Special Dividend

The Company has finalised the arrangements for completion of the Special Dividend and the Board currently anticipates payments of the Special Dividend later this month.

For further information contact:

 
OKYO Pharma Corporation                        Willy Simon        [phone] 
                                               Roland Cornish 
Beaumont Cornish Limited (Nominated Adviser)    Michael Cornish   [phone] 
 

Further information is available on the Company's website: www.okyopharma.com

This announcement is inside information for the purposes of Article 7 of Regulation 596/2014. The person who arranged for the release of this announcement on behalf of the Company was Willy Simon, Director.

APPENDIX

DEFINITIONS

In this announcement, the following expressions have the following meanings unless the context otherwise requires:

 
 "AIM"                the market of that name operated 
                       by the London Stock Exchange 
 "Articles"           articles of association or articles 
                       of incorporation of the Company 
                       in force from time to time including, 
                       with effect from Migration, the 
                       New Articles 
 "Cancellation"       the proposed cancellation of admission 
                       of the Ordinary Shares from trading 
                       on AIM 
 "Company" or         (i) as at the date of this document, 
  "OKYO"               OKYO Pharma Corporation, and (ii) 
                       subject to re-registration following 
                       Cancellation and completion of the 
                       Migration, OKYO Pharma Limited. 
 "Ferrum"             Ferrum Resources Limited 
 "Ferrum Shares"      the ordinary shares of no par value 
                       in the capital of Ferrum 
 "General Meeting"    the general meeting of the Company 
                       held at 10.00 a.m. on 9 March 2018 
 "Migration"          the continuation of the Company 
                       out of the British Virgin Islands 
                       and migration of the Company into 
                       Guernsey 
 "New Articles"       the proposed new articles of incorporation 
                       compliant with Guernsey law, to 
                       be adopted upon Migration in place 
                       of the Company's existing articles 
                       of association 
 "Ordinary Shares"    ordinary shares of no par value 
                       in the capital of the Company 
 "Shareholders"       holders of Ordinary Shares 
 "Special Dividend"   the distribution of Ferrum Shares 
                       to Shareholders 
 
 
 

ENDS

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCFKCDPKBKDFNK

(END) Dow Jones Newswires

March 09, 2018 06:01 ET (11:01 GMT)